Virtu KCG Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.87M Sell
7,685
-2,240
-23% -$526K 0.05% 279
2017
Q1
$2.37M Buy
+9,925
New +$2.31M 0.07% 209
2016
Q4
Sell
-34,624
Closed -$7.97M 3982
2016
Q3
$7.97M Buy
34,624
+29,538
+581% +$7.22M 0.19% 42
2016
Q2
$1.18M Sell
5,086
-51,001
-91% -$11.8M 0.02% 636
2016
Q1
$15M Buy
56,087
+41,860
+294% +$12M 0.42% 13
2015
Q4
$4.45M Sell
14,227
-6,301
-31% -$1.88M 0.08% 165
2015
Q3
$5.58M Buy
20,528
+16,439
+402% +$5.05M 0.09% 127
2015
Q2
$1.24M Sell
4,089
-32,643
-89% -$9.74M 0.02% 678
2015
Q1
$10.9M Buy
36,732
+23,137
+170% +$6.6M 0.22% 43
2014
Q4
$3.5M Buy
13,595
+3,643
+37% +$911K 0.06% 223
2014
Q3
$2.4M Sell
9,952
-33,216
-77% -$7.43M 0.05% 365
2014
Q2
$9.62M Buy
43,168
+38,078
+748% +$7.88M 0.15% 78
2014
Q1
$1.05M Buy
5,090
+3,298
+184% +$653K 0.01% 1192
2013
Q4
$301K Buy
+1,792
New +$280K ﹤0.01% 2593

Other funds holding AGN

Virtu KCG Holdings's AGN Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Allergan plc (AGN) stake by 23% in Q2 2017, selling an estimated $526K and leaving 7,685 shares worth $1.87M. The position accounts for 0.05% of the portfolio, ranked #279.

Virtu KCG Holdings first reported a position in AGN in Q4 2013 and has held it in 14 quarters since. The position peaked at $15M in Q1 2016. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Virtu KCG Holdings held 7,685 shares of Allergan plc worth $1.87M as of Q2 2017.
  • Virtu KCG Holdings sold 2,240 Allergan plc shares in Q2 2017, an estimated $526K.
  • Allergan plc made up 0.05% of Virtu KCG Holdings's portfolio in Q2 2017, its #279 holding.
  • Virtu KCG Holdings first reported a position in Allergan plc in Q4 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's Allergan plc position peaked at $15M in Q1 2016.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.